RMD Q3 2025 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

Q3 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$1.3B+7.9% YoY

Gross Profit

$766M59.3% margin

Operating Income

$426M33.0% margin

Net Income

$365M28.3% margin

EPS (Diluted)

$2.48

QoQ Revenue Growth

+0.8%

Cash Flow

Operating Cash Flow

$579M

Free Cash Flow

$555M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$7.6B

Total Liabilities

$2.0B

Stockholders' Equity

$5.5B

Cash & Equivalents

$933M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$1.2B	+7.9%
Gross Profit	$766M	$682M	+12.4%
Operating Income	$426M	$375M	+13.8%
Net Income	$365M	$300M	+21.5%